The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism
-
Add time:08/21/2019 Source:sciencedirect.com
We have previously reported that MCI-225, a selective noradrenaline (NA) reuptake inhibitor with serotonin (5-HT)3 receptor antagonism, shows antidepressant-like properties in experiments using rodents. In this study, we investigated the effect of MCI-225 in anxiety models in comparison with diazepam, ondansetron, maprotiline, imipramine, and trazodone. In social interaction (SI) test in rats, MCI-225 (10 and 30 mg/kg, po), diazepam (1–10 mg/kg, po), and a selective 5-HT3 receptor antagonist ondansetron (1 mg/kg, po) significantly increased SI to an unfamiliar partner under high light conditions without changes in ambulation. The increase in SI induced by MCI-225 and ondansetron was blocked by a 5-HT3 agonist, 1-(m-Chlorophenyl)-biguanide (mCPBG, 1 mg/kg, ip), which did not change SI when administered alone. MCI-225 (10 mg/kg, po) showed comparable anxiolytic-like effect between single and 5-day repeated administration. On the other hand, maprotiline, trazodone, and imipramine did not affect SI at doses of 3–30 mg/kg, po. In the elevated plus-maze test in rats, MCI-225 (10–100 mg/kg, po) increased the number of entries into the open arms only, while diazepam increased not only the number of open-arms entries (30 mg/kg, po), but also the total number of entries (10 mg/kg, po). Ondansetron (0.001–1 mg/kg, po) was less effective. Maprotiline, imipramine, and trazodone did not affect the number of open-arm entries, while trazodone and imipramine (100 mg/kg, po) decreased the total number of entries. These results show that MCI-225 has an anxiolytic-like effect without causing sedation and suggest that the 5-HT3 receptor antagonism of MCI-225 probably contributes to its anxiolytic-like property.
We also recommend Trading Suppliers and Manufacturers of MCI 225 (cas 135991-48-9). Pls Click Website Link as below: cas 135991-48-9 suppliers
Prev:Effects of a novel compound MCI-225 on impaired learning and memory in rats
Next:ArticlesMCI-225, A Novel Thienopyrimidine Analog, Enhances Attentional Eye Tracking in Midpontine Pretrigeminal Preparation) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Featured ArticleAD dementia risk in late MCI, in early MCI, and in subjective memory impairment08/26/2019
- A theoretical model for the production of Ac-225 for cancer therapy by neutron capture transmutation of Ra-22608/25/2019
- Cyclotron and linac production of Ac-225☆08/24/2019
- Production of actinium-225 for alpha particle mediated radioimmunotherapy08/23/2019
- ArticlesMCI-225, A Novel Thienopyrimidine Analog, Enhances Attentional Eye Tracking in Midpontine Pretrigeminal Preparation08/22/2019
- Effects of a novel compound MCI-225 on impaired learning and memory in rats08/20/2019
- ArticleEffects of MCI-225 on memory and glucose utilization in basal forebrain-lesioned rats08/19/2019


